1. Microsomal membranes from rat liver were incubated with ATP, CoA, Mg2+, [14C]palmitate, F-and sn-glycerol 3-phosphate in order to label them with [14C]phosphatidate. These membranes were isolated and used in a second incubation in which [3H]CTP was present, and the simultaneous synthesis of [14C]diacylglycerol and [3H]CDP-diacylglycerol was measured. 2. The addition of phosphatidate phosphohydrolase, which had been partially purified from the particle-free supernatant, supplemented the activity of the endogenous phosphohydrolase, but it did not alter the rate of CDP-diacylglycerol formation. 3. Adding EDTA inhibited phosphatidate cytidylyltransferase activity and stimulated the activity of the phosphohydrolases by removing excess of Mg2+. 4. Increasing the concentration of Mg2+, norfenfluramine or chlorpromazine in the assay system stimulated cytidylyltransferase activity, but decreased the activities of both phosphohydrolases. 5. The mechanism for the stimulation of cytidylyltransferase activity by the cationic drugs and Mg2+ was investigated with emulsions of phosphatidate and the microsomal fraction of rat liver. 6. There was a threshold concentration of about 5 mm-MgCl2 below which no cytidylyltransferase activity was detected in the presence or absence of norfenfluramine. Just above this threshold concentration norfenfluramine stimulated cytidylyltransferase activity, but this stimulation disappeared as the Mg2+ concentration was raised to its optimum of 20mM. Norfenfluramine therefore partially replaced the bivalent-cation requirement. 7. At 30mM-MgCI2 amphiphilic cationic drugs inhibited cytidylyltransferase activity at relatively high concentrations in a non-competitive manner with respect to phosphatidate. 8. The implications of these results are discussed with respect to the regulation of the synthesis of the acidic phospholipids compared with the synthesis of phosphatidylcholine, phosphatidylethanolamine and triacylglycerol.
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Drugs such as the phenothiazine neuroleptics, tricyclic antidepressants, local anaesthetics, fenfluramine and its derivatives, propanolol and other fl-adrenergic-blocking agents and some narcotic drugs lead to profound changes in glycerolipid metabolism in a variety of tissues. These compounds all contain a hydrophobic region and a primary or substituted amine which can bear a positive charge. They can therefore be classified as amphiphilic cations. These drugs all decrease the rates of synthesis of triacylglycerol and the zwitterionic phospholipids, phosphatidylcholine and phosphatidylethanolamine. At the same time phosphatidate and other acidic phospholipids such as CDP-diacylglycerol, phosphatidylinositol and phosphatidylglycerol accumulate (for references, see Eichberg & Hauser, 1974 Brindley & Bowley, 1975a,b; Michell et al., 1976; AbdelVol. 162 Latif & Smith, 1976) . These amphiphilic cations have been shown to inhibit the activity of phosphatidate phosphohydrolase (EC 3.1.3.4) (Brindley & Bowley, 1975a,b) and this action could explain many of their effects on lipid synthesis (Eichberg & Hauser, 1974; Brindley et al., 1975) .
It has been proposed that the inhibition of phosphatidate phosphohydrolase might involve an interaction between phosphatidate and the positively charged drugs (Brindley & Bowley, 1975a Unless stated to the contrary, cofactors, substrates and reagents were prepared or purchased as described previously (Stnchez et al., 1973; Mangiapane et al., 1973; Brindley & Bowley, 1975a) . CTP (Na+ salt, from yeast) was purchased from Sigma (London) Chemical Co., Kingston-upon Mangiapane et al, (1973) .
However, the livers were perfused in situ with icecold 0.9% NaCl when the particle-free supernatant was to be used as a source of enzyme. Preparation ofphospholipase D (EC 3.1.4.4) The method was essentially that of Davidson & Long (1958) , but white celery was used for the preparation. Celery stalks (300g) were homogenized in 450ml of water in a blender, The homogenate was filtered through cheesecloth and centrifuged at 13000g for 30min. The supernatant was taken as a source of crude enzyme and used immediately. Preparation ofpartially purified phosphatidate phosphohydrolase
The soluble phosphatidate phosphohydrolase obtained from the particle-free supernatant of perfused rat livers was purified by the method of Hosaka et al. (1975) . The protein obtained after the (NH4)2S04 precipitation was dialysed overnight at 4°C against 0.3M-sucrose containing 0.5mM-dithiothreitol immediately before use. This gave an approximately 6-fold increase in the specific activity compared with that of the particle-free supernatant. by coolng tho rem.tion mixture in an ice bath, The mixture was layered over 0.3M-sucrose containing 0.5mM-dithiothreitol and centrifuged for 90min at 40C and 76000g (ra. =7.62cm). The pellets which contained the newly synthesized phosphatidate were resuspended in fresh sucrose/ dithiothreitol medium. Analysis of the 'IC-labelled lipid by t.l.c. (Brindley & Bowley, 1975a) showed that approx. 87 % of the esterified [14C]palmitate was present in phosphatidate, with approx. 8% being divided equally between diacylglycerol and triacylglycerol.
Preparation ofpotassium phosphatidate
Phosphatidate was prepared by hydrolysis of phosphatidylcholine by phospholipase D. Phosphatidylcholine from egg yolk was purified by chromatography on aluminium oxide (Singleton et al., 1965) and eluted with chloroform/methanol (9:1, v/v). It was then treated with the phospholipase D for 5 days at room temperature (about 229C) essentially as described by Agranoff & Suomi (1963) . The ether phase was removed and the aqueous phase plus the interface were then extracted three times with chloroform. The combined chloroform and ether phases were evaporated to dryness under reduced pressure. The residue was applied in chloroform to a silicic acid column and neutral lipids were eluted with chloroform. The phosphatidate was then eluted with chloroform/methanol (93:7, v/v) and the solvent evaporated under reduced pressure. The product was converted into potassium phosphatidate by chromatography on Chelex resin (KI form; Renkonen, 1969) . Emulsions of phosphatidate (15mol/ml) were prepared after the removal of solvent by sonication for about 2 min in water at 22kHz under an atmosphere of N2.
Assay ofphosphatldate cytidylyltransferase activity by using emulsions ofphosphatidate The method of assay was similar to that described by Carter & Kennedy (1966) . Each assay contained in a final volume of 0.25ml: lOOmM-Tris buffer adjusted to pH7.4 with HCI, 2mm-potassium (30mM) in the assay system. The concentrations of these drugs which were required to produce a 50% inhibition of the cytidylyltransferase were higher than those which produced an equivalent inhibition of phosphatidate phosphohydrolase activity (Table 1) . This is most marked for norfenfluramine and hydroxyethylnorfenfuramine. However, demethylimipramine and chlorpromazine were fairly effective inhibitors ofthe cytidylyltransferase activity. The inhibition of phosphatidate cytidylyltransferase activity was of a non-competitive type (Fig. 1) , but it exhibited non-lincar kinetics. This may be caused partly by the difficulties in defining the concentration of phosphatidate which is probably more related to the effective surface area of the phosphatidate emulsions than to its absolute concentration (Brindley & White, 1974) . A strict kinetic interpretation is therefore not possible. However, the relative inhibition of the cytidylyltransferase activity by chlorpromazine was independent of the phosphatidate concentration.
The inhibition by chlorpromazine was reversed when the membranes were centrifuged through 0.3M-sucrose containing 6mg of fatty acid-poor bovine serum albumin/ml and 0.5mM-dithiothreitol, and the rate of the inhibited reaction was constant with time up to 15min. These two observations support the conclusion that the inhibition was of a non-competitive rather than of an irreversible type. The inhibition of cytidylyltransferase and of glycerol phosphate acyltransferase probably results from an interaction of the cationic drugs with the microsomal membranes. The concentrations of cationic drugs required for a 50% inhibition of these two enzymes (Table 1) (Brindley & White, 1974) and which has been widely used for studying the properties of phosphatidate phosphohydrolase. During the course of this work a paper also appeared on its use for studying the specificity of the cytidylyltransferase (Holub & Piekarski, 1976) . The experiments described in Fig. 2 Phosphatidate phosphohydrolase was also partially purified from the particle-free supernatant of rat liver and was added in some experiments. The addition of this phosphohydrolase did not significantly decrease the rate of synthesis of CDP-diacylglycerol in four experiments, even though the flux of phosphatidate to diacylglycerol was increased (see also Fig. 2 ). Adding norfenfluramine decreased the utilization of phosphatidate in the presence of soluble phosphohydrolase, owing to an inhibition of the combined phosphohydrolase activity (Fig. 2a) . Fig. 2(a) shows the results from one experiment, since the absolute activity of the phosphohydrolase varied with different preparations. However, in three independent experiments the addition of 1.75mM-norfenfIiramine caused a 62±8% (S.D.) decrease in the utilization of phosphatidate. The membranebound and the soluble phosphohydrolase activities were inhibited to similar extents. At the same concentration of norfenfluramine the synthesis of CDP-diacylglycerol was increased by 3.1 ±0.3-fold. In the experiment shown in Fig. 2(a) Similar results were obtained with chlorpromazine. In two experiments a maximum stimulation in the synthesis of CDP-diacylglycerol of 2.6-and 2.8-fold was obtained with 0.35mM-chlorpromazine. This concentration of chlorpromazine decreased the average activity of the membrane-bound and soluble phosphohydrolases by 65 % and 55 % respectively. Fig. 2(b) shows the effect of changing the concentration of Mg2+ on the relative utilization ofphosphatidate by the phosphohydrolase and the cytidylyltransferase. This effect is remarkably similar to that obtained with norfenfluramine and chlorpromazine. Addition of 20mM-MgCl2 gave a 3.3 ±0.3 (S.D. from three experiments) -fold increase in the activity of the cytidylyltransferase. The phosphohydrolase activities were completely inhibited by adding 20mM-MgCl2.
The ["C]phosphatidate in the preparation contained some Mg2+ which was probably bound to it during the first incubation which was used to prelabel the membranes. This concentration of Mg2+ was inhibitoryfor thephosphohydrolase and a stimulation ofabout 3.3-fold was obtained by adding 2mM-EDTA Vol. 162 (Fig. 3) . Higher concentrations of EDTA inhibited when the effective concentration of Mg2+ required for the phosphohydrolase reaction became suboptimum. It is already known that a Mg2+ requirement is only observed for the phosphatidate phosphohydrolase acting on membrane-bound phosphatidate when the latter is extensively treated with EDTA (Mitchell et al., 1971) . Addition of EDTA in the present experiments completely inhibited the cytidylyltransferase activity.
Interaction between Mg2+ and norfenfluramine on the activity ofphosphatidate cytidylyltransferase
The effects of Mg2+ and norfenfluramine in promoting the flux of phosphatidate towards CDPdiacylglycerol and away from diacylglycerol were similar (Fig. 2) . Cationic drugs are known to compete with bivalent cations for binding sites in membranes and on acidic phospholipids (Mule, 1969; Dawson & Hatser, 1970; Papahadjopoulos, 1970; Papahadjopoulos et al., 1975) . It was therefore decided to investigate the interaction of Mg2+ and norfenflur- In Expt. 1 (e) 820jug of protein from the particle-free supernatant was added to each incubation, whereas in Expt. 2 (A) 200pg of protein from a partially purified preparation of soluble phosphatidate phospholydrolase. was used. The rates of diacylglycerolsynthesis in the absen'ce of EEDTA were 0.21 and 0.50nmol/min inExpts. 1 and 2 respectively and these are given the value. of 100 in the Figure. amine on the activity of phosphatidate cytidylyltransferase by using emulsions of phosphatidate. Mg2+ requirement for the cytidylyltransferase is shown in Fig. 4 . There seems to be a threshold concentration of Mg2+ below which no enzyme activity is observed. Above this threshold the activity rises sharply and maximum velocities are obtained at about 20mM-MgCl2. The requirement for Mg2+ appears to vary from experiment to experiment, and this is probably caused by the differences in the physical properties of the phosphatidate in different emulsions.
The interaction of norfenfluramine and Mg2+ is shown in Fig. 5 , and these results were obtained in Expt. 5 (Fig. 4) . At 5mM-MgCl2 a 5.3-fold stimulation of cytidylyltransferase activity was obtained by adding 1.75mM-norfenfluramine. As the concentration of Mg2+ was raised, the stimulation produced by norfenfluramine was decreased. At 20mM-Mg2+, which was an optimum concentration (Fig. 4) , norfenfluramine produced no significant stimulation of CDP-diacylglycerol formation (Fig. 5) . Fig. 5 contains the results from only one experiment, since the requirement for I82+ varied in different experiments (Fig. 4) . However, the effect of norfenfluranine was similar in four independent experiments. In three experiments (including Expts. 1 and 3 of Fig. 4) , there was no cytidylyltransferase activity at 5mM-MgCl2 and the addition of norfenfluramine caused no stimulation of the acti'vity. [MgCI2J (MM) Fig. 4 Fig. 4 ) the addition of 1.75mM-norfenfluraine produced a 3.1-foldstimulation ofcytidylyltransferase activity. Similarly in Expt. 3 (Fig. 4 ) the same concentration of norfenfluranine stimulated the synthesis of CDP-diacylglycerol by 5.6-fold, but this was at 7mM-MgCl2. Norfenfluramine therefore appears to be partially butnotcompletelyreplacingtherequirementforMg2+ in the cytidylyltransferase reaction. This expla the norfenfluramine-induced stimulation of CDPdiacylglycerol synthesis observed in Fig. 2(a) (Raetz et al., 1976 Fig. 1 ). In contrast, phosphatidate phosphohydrolase is more sensitive to inhibition by these compounds and the inhibition is competitive with respect to phosphatidate (M. Bowley, J. Cooling, S. Burditt & D. N. Brindley, unpublished work) . This means that at concentrations ofphosphatidate as low as those that occur in the cell the inhibition of the phosphohydrolase should be accentuated. Norfenfluramine (Fig. 2a) and chlorpromazine (not shown) inhibited the utilization of membrane-bound [14C]phosphatidate by decreasing its conversion into diacylglycerol while at the same time stimulating its flux to CDPdiacylglycerol. These results demonstrate how Vol. 162 catlonic drugs enhance the accumulation of phos. phatidate and how they redirect phospholipid metabolism towards the synthesis of acidic lipids, as was predicted earlier (Brindley et al., 1975) .
The increased synthesis of CDP-diacylglycerol was not caused by a greater availability of phosphatidate which resulted from the inhibition of the phosphohydrolase (Fig. 2) . The addition of partially purified phosphatidate phosphohydrolase to the membrane-bound phosphatidate enhanced the synthesis of diacylglycerol, but produced no significant change in the rate of CDP-diacylglycerol synthesis. Chlorpromazine and norfenfluramine actively stimulated the cytidylyltransferase activity, but only at low concentrations of Me+ (Fig. 5) . The observed interaction of the cationic drugs with phosphatidate (Mule, 1969; Ohki, 1970) will alter the physical state of the phosphatidate, including such properties as the effective electrical potential (Papahadjopoulos, 1970 ). This appears to favour the activity of the cytidylyltransferase and inhibits phosphatidate phosphohydrolase (Fig. 2a) . Higher concentrations of Mg2+ have the same effect ( Fig. 2b ) and remove the stimulation by chlorpromazine and norfenfluramine (Fig. 5) . The amphiphilic drugs and Mg2+ therefore appear to be having a complementary effect rather than to be acting antagonistically. However, the cationic drugs cannot completely replace the Mg2+, since below the threshold value for Mg2+ (Fig. 4 ) the stimulatory effect of the drugs is not observed. This probably means that the cytidylyltransferase recognizes Mg2+ phosphatidate as its substrate but in addition requires that the phosphatidate should be in a suitable physical form. This property and the ability of a bivalent cation to modify the relative flux of phosphatidate to diacylglycerol and to CDP-diacylglycerol might be used by the cell to regulate the synthesis of the neutral and acidic glycerolipids. The average concentration of Mg2+ in rat liver is about 8mM (Long, 1961) and thus the effects of Mg2+ on phosphatidate utilization, which are reported here, occur within the physiological range.
Although the results presented in this paper do provide an explanation for many of the alterations in lipid metabolism that are observed with amphiphilic cations, there may well be other effects. These compounds preferentially interact with acidic phospholipids (Papahadjopoulos et al., 1975) and therefore any enzymes acting on this type of substrate are potential target sites. Propranolol has been shown to increase the synthesis of phosphatidylserine by stimulating the Ca2+-catalysed base-exchange reaction (Abdel-Latif & Smith, 1976) . Chlorpromazine and tetracaine inhibit the synthesis of phosphatidylinositol from CDP-diacylglycerol and decrease its rate of catabolism (Jungalwala et al., 1971; Freinkel et al., 1975) . The net effect of amphiphilic cations on the metabolism of acidic phospholipids probably depends on which enzyme reaction is rate-limiting, and this probably varies in different tissues and under different physiological conditions.
The general ability of amphiphilic cationic drugs to interact with acidic phospholipids, thus changing their physical properties and also their metabolic turnover, seems to be involved in a number of important pharmacological phenomena. (1) It may partly explain the effects of the fenfluramine derivatives in decreasing the rate of triacylglycerol synthesis and the secretion of very-low-density lipoproteins (Brindley & Bowley, 1975b; Brindley et al., 1976) . (2) It is probably the basis for the phospholipidosis which is observed after prolonged treatment with high doses of certain amphiphilic cationic drugs (Michell et al., 1976) . (3) It is probably involved in the interaction of the drugs with biological membranes and their effects on membrane movement, fusion, permeability, transport and receptor function (Papahadjopoulos et al., 1975; Brindley et al., 1975) .
